The Purpose of the COA Compendium The pilot COA Compendium (view PDF) is part of FDA’s efforts to foster patient-focused drug development. The COA Compendium is intended to facilitate communication
PLAINSBORO, N.J., Dec. 9, 2015 /PRNewswire/ — Novo Nordisk announced the submission to the U.S. Food and Drug Administration of a New Drug Application (NDA) for faster-acting insulin aspart, a
Researchers from Australia say they may have uncovered a way to make the seasonal flu vaccine more effective, by adding a string of synthetic fat molecules that boost the body’s
In recent years, several developers have created mobile apps that allow diabetic patients to track their blood glucose readings, but a new application from Philips Healthcare has taken this concept
Over the past decade, 3-D printers have been hailed as changing everything from fashion to firearms.
